In The Spotlight
DDNews Cancer Research Exclusive
 
 
Recent work with nanoparticles offers a new approach to photo-thermal cancer therapies
 
(Photo credit: University of Toronto)
 
The PEARLs (Photothermal Enhancing Auto-Regulated Liposomes) were developed by Dr. Gang Zheng of the Princess Margaret Cancer Centre and University of Toronto and colleagues, who say they overcome traditional roadblocks to penetrate deeper into tumors.
 
 
NEWS
Company is to validate new targets linked to myeloid cells and identify innovative new immunotherapies in oncology
 
Phase 2 study achieves primary endpoint, with topical endoxifen rapidly reducing breast density
 
Cytodyn doses first mTNBC patient
 
Monopar Therapeutics Inc. announced last month that it had begun a clinical collaboration agreement with the Spanish Sarcoma Group to conduct a Phase 2 clinical trial assessing Monopar's Camsirubicin in patients with advanced soft tissue sarcoma
 
Boehringer Ingelheim and MD Anderson form unique R&D center to rapidly advance new cancer treatments
 
Interpace purchases Biopharm Services business from Cancer Genetics
 
Agendia Inc. reported recently that its MammaPrint Breast Cancer Risk-of-Recurrence Test is the only molecular diagnostic indicated for use in patients whose breast cancer has spread to their lymph nodes
 
Orion Biotechnology reports additional positive preclinical data for OB-002
 
  
FEATURES
 
 
Glioblastoma remains a difficult cancer to treat, but the brain malignancy is seeing increasing attention in R&D
 
OPINION
Guest Commentary: ACT clinical trials--The long road
by Martin Lachs/Brandon Fletcher
As excitement and investment related to adoptive cell transfer products increases, there are concerns and issues that need to be addressed in terms of long-term follow-up trials

Open Science approaches to the treatment of a rare childhood cancer
by Sue Cramp, Charles River
In pursuit of new options for treating childhood cancers, a new approach to drug discovery and development may be an answer

Guest Commentary: The growing potential of CAR T-cell therapy
by Andrea Toell of Lonza
Andrea Toell of Lonza shares how CAR T cells are transforming immuno-oncology

 
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.